Walgreens Boots Alliance, Inc. (WBA)
| Market Cap | 9.53B |
| Revenue (ttm) | 151.95B |
| Net Income (ttm) | -5.78B |
| Shares Out | 864.74M |
| EPS (ttm) | -6.69 |
| PE Ratio | n/a |
| Forward PE | 6.83 |
| Dividend | n/a |
| Ex-Dividend Date | Nov 18, 2024 |
| Volume | 4,094,203 |
| Open | 11.03 |
| Previous Close | 10.99 |
| Day's Range | 11.00 - 11.08 |
| 52-Week Range | 8.08 - 18.83 |
| Beta | 0.64 |
| Analysts | Hold |
| Price Target | 10.59 (-3.86%) |
| Earnings Date | Apr 8, 2025 |
About WBA
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of p... [Read more]
Financial Performance
In 2024, Walgreens Boots Alliance's revenue was $147.66 billion, an increase of 6.17% compared to the previous year's $139.08 billion. Losses were -$8.64 billion, 180.4% more than in 2023.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for WBA stock is "Hold." The 12-month stock price forecast is $10.59, which is a decrease of -3.86% from the latest price.
News
Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens, the nation's largest independent community pharmacy provider, has teamed up with Guild, the leading talent development company, to launch PharmStart, a fir...
Walgreens agrees to pay US up to $350m for illegally filling opioid prescriptions
Drugstore chain settles with DoJ over claims it dispensed millions of unlawful prescriptions for more than a decade
Walgreens to pay up to $350M for filling illegal opioid prescriptions, Justice Department says
Walgreens has agreed to pay up to $350 million to resolve claims that the company illegally filled millions of invalid prescriptions for opioids.
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is calling on the public to help in the fight against prescription drug abuse by participating in National Prescription Drug Take Back Day on Saturday, Apri...
Walgreens settles allegations of filling invalid opioid prescriptions for $300 million, US DOJ says
Walgreens Boots Alliance and its subsidiaries have agreed to pay $300 million to settle U.S. allegations that the pharmacy chain illegally filled millions of invalid prescriptions for opioids and othe...
Walgreens: Acquisition Is The Best-Case Scenario For The Company
Walgreens Boots Alliance faces significant challenges, including rising inflation, heavy competition, and decreasing profitability, making it a Hold if the acquisition by Sycamore goes through. The co...
Walgreens Boots Alliance: Last Change To Buy
Walgreens Boots Alliance faces significant challenges, including declining margins, rising labor costs, and fierce competition from online pharmacies and retail giants like Amazon and Walmart. The pro...
WBA stock price: Walgreens beats on revenue in one of its last earnings reports as a public company
Shares in Walgreens Boots Alliance (Nasdaq: WBA) are trading slightly higher this morning after the company reported its Q2 2025 earnings. The results, which beat on earnings and revenue, are notable ...
Walgreens Continues Turnaround Efforts Ahead of Planned Acquisition by Private Equity Firm
Walgreens Boots Alliance (WBA) saw its second-quarter fiscal 2025 sales increase and its operating loss drop as it continues its turnaround plan and prepares to be acquired. The retail pharmacy compan...
Measuring WBA Merger, HUM "Bonds Play," CVS & UNH Options Trades
Spencer Hakimian believes the healthcare sector will withstand the tariff storm well compared to other industries. On specific stocks, he doesn't expect much movement from Walgreens (WBA) after its to...
Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Tuesday.
Walgreens turnaround still in its early stages, says CEO, as buyout looms
Walgreens Boots Alliance Inc. shares are up 1.2% in premarket trades after the drugstore chain reported better-than-expected second-quarter revenue and adjusted earnings, boosted by an improvement in ...
Walgreens tops estimates as drugstore chain cuts costs - prepares to go private
CNBC's Becky Quick reports on the company's quarterly earnings results.
Walgreens Sales Rise on U.S. Retail Pharmacy Segment Growth
Walgreens Boots Alliance posted higher sales in its latest quarter on growth in retail-pharmacy sales in the U.S., in one of the last quarterly reports the company will publicly file ahead of its tran...
Walgreens tops estimates as drugstore chain cuts costs, prepares to go private
Walgreens reported fiscal second-quarter earnings and revenue that topped expectations, as the retail drugstore giant prepares to go private. In this article WBA
Walgreens' second-quarter profit beats ahead of Sycamore Partners deal close
Walgreens , which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly profit on Tuesday as the pharmacy chain operator benefited from a turnaround e...
Walgreens Boots Alliance Reports Fiscal 2025 Second Quarter Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2025, which ended February 28, 2025. Chief Executive O...
Top Wall Street Forecasters Revamp Walgreens Price Expectations Ahead Of Q2 Earnings
Walgreens Boots Alliance, Inc. WBA will release earnings results for the second quarter, before the opening bell on Tuesday, April 8.
How To Earn $500 A Month From Walgreens Stock Ahead Of Q2 Earnings
Walgreens Boots Alliance, Inc. WBA will release earnings results for the second quarter, before the opening bell on Tuesday, April 8.
Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Walgreens Settles Allegations of Submitting Inflated Prices to Medicaid Programs
Walgreens has agreed to pay $2.8 million to settle allegations that it submitted inflated prices to the Massachusetts and Georgia Medicaid programs for generic medications.
Walgreens to pay more than $2.85 million to settle US overbilling charges
Walgreens will pay more than $2.85 million to settle whistleblower allegations that the pharmacy overbilled Medicaid programs in Georgia and Massachusetts for generic medications, the U.S. Department ...
Walgreens Agrees to Pay About $2.8 Million to Resolve Medicaid-Overbilling Allegations
Walgreens agreed to pay about $2.8 million to the federal government and the states of Massachusetts and Georgia to settle allegations that the company inflated prices for generic medications covered ...
Walgreens Boots' Stefano Pessina to almost double stake after Sycamore takeover, FT reports
Walgreens Boots Alliance's executive chair Stefano Pessina will almost double his stake in the US pharmacy group to about 30% as part of its takeover by private equity group Sycamore, the Financial Ti...